who will be able to afford the new drugs?

coordinated by Luigi Ripamonti

The pharmaceutical industry is by now oriented above all towards the development of biotechnological drugs, which are targeted and effective, but much more expensive than traditional chemically synthesized drugs. The challenge for the future is thus linked to sustainability. How is it possible to allow universal access to treatment and at the same time to guarantee a fair profit, so as not to penalise research?
lingua dei segni


02 17:30

venerdì 02 giugno 2017
17:30 - 18:45